Nepal received 345,600 doses of Pfizer-BioNTech’s bivalent Covid-19 vaccine on Monday. Dr Sarvesh Sharma, Director at the Department of Health Services of the Management Division, said that Nepal received 345, 600 doses of Covid-19 vaccine in the first phase from the COVAX facility today. “Nepal was supposed to receive 1.5 million doses of Pfizer-BioNTech’s bivalent Covid-19 vaccine. But, the COVAX Facility sent 345, 600 doses of Covid-19 vaccine in the first phase. Nepal will receive remaining doses of Covid-19 vaccine in a few days,” he said.

Dr Sharma said that the vaccines will be stored in Teku Hospital.

This vaccine is considered to be effective against sub-variants of Omicron.